Interim post-progression data and updated survival in patients with newly diagnosed advanced ovarian cancer in ATHENA-MONO

被引：0

作者：

Kristeleit, Rebecca ^{[1
]}

O'Malley, David ^{[2
]}

Lim, Myong Cheol ^{[3
]}

Miller, Rowan ^{[4
]}

Herzog, Thomas ^{[5
]}

Wilson, Michelle ^{[6
]}

De Vivo, Rocco ^{[7
]}

Coleman, Robert ^{[8
]}

Oaknin, Ana ^{[9
]}

Oza, Amit ^{[10
]}

Mikheeva, Olga ^{[11
]}

Buscema, Joseph ^{[12
]}

Chudecka-Glaz, Anita ^{[13
]}

Van Le, Linda ^{[14
]}

Van Gorp, Toon ^{[15
]}

Moore, Kathleen ^{[16
]}

Zagouri, Flora ^{[17
]}

Morris, Robert ^{[18
]}

Rob, Lukas ^{[19
,20
]}

Craib, Marcia ^{[21
]}

Connor, Christy ^{[21
]}

Shih, Danny ^{[21
]}

Fujiwara, Keiichi ^{[22
]}

Monk, Bradley ^{[23
,24
,25
]}

机构：

[1] Guys & St Thomas NHS Fdn Trust, London, England

[2] Ohio State Univ, Columbus, OH 43210 USA

[3] Natl Canc Ctr, Goyang Si, Gyeonggi Do, South Korea

[4] Univ Coll London Hosp, London, England

[5] Univ Cincinnati, Cincinnati, OH USA

[6] Auckland City Hosp, Auckland, New Zealand

[7] Osped San Bortolo, Vicenza, Italy

[8] US Oncol Res, Spring, TX USA

[9] Vall dHebron Hosp Univ, Barcelona, Spain

[10] Princess Margaret Hosp, Ctr Canc, Toronto, ON, Canada

[11] Ltd Liabil Co MedPomosch, St Petersburg, Russia

[12] Arizona Oncol Associates, Tucson, AZ USA

[13] Independent Publ Clin Hosp 2 PUM, Szczecin, Poland

[14] Univ North Carolina Chapel Hill, Chapel Hill, NC USA

[15] Univ Ziekenhuizen Leuven, Leuven, Belgium

[16] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA

[17] Alexandra Hosp, Athens, Greece

[18] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA

[19] Charles Univ Prague, Prague, Czech Republic

[20] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic

[21] Pharma&, Broomfield, CO USA

[22] Saitama Med Univ Int Med Ctr, Hidaka, Japan

[23] GOG Fdn, Phoenix, AZ USA

[24] Univ Arizona, Phoenix, AZ USA

[25] Creighton Univ, Omaha, NE 68178 USA

来源：

GYNECOLOGIC ONCOLOGY | 2024年 / 190卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S10 / S11

页数：2

共 50 条

[1] The use of bevacizumab is correlated with improved post-progression survival in advanced recurrent ovarian cancer
Yanazume, Shintaro
Ushiwaka, Takashi
Fukuda, Mika
Togami, Shinichi
Kamio, Masaki
Kobayashi, Hiroaki
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (09) : 1407 - 1415
[2] Rucaparib maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC): Defining benefit according to disease risk subgroups within the phase 3 ATHENA-MONO study
Kristeleit, R.
Ghamande, S.
Lim, M-C.
Parkinson, C.
Morgan, M.
Wilson, M.
Oaknin, A.
Buscema, J.
Bessette, P.
Lorusso, D.
Ueland, F.
Safra, T.
Barlin, J.
Marme, F.
Herzog, T. J.
McNeish, I.
Goble, S.
Hume, S.
Fujiwara, K.
Monk, B. J.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S786 - S787
[3] Rucaparib maintenance treatment in patients (Pts) with newly diagnosed ovarian cancer (OC): defining benefit according to disease risk subgroups within the phase 3 ATHENA-MONO study
Lorusso, Domenica
Kristeleit, Rebecca S.
O'Malley, David M.
Lim, Myong Cheol
Agarwal, Roshan
Herzog, Thomas J.
Wilson, Michelle K.
Oaknin, Ana
Coleman, Robert L.
Oza, Amit
Mikheeva, Olga
Copeland, Larry J.
Kose, Fatih
Jewell, Andrea
Chudecka-Glaz, Anita
Craib, Marcia L.
Connor, Christy L.
Shih, Danny
Fujiwara, Keiichi
Monk, Bradley J.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A298 - A299
[4] Correlation of progression-free and post-progression survival with overall survival in advanced colorectal cancer
Petrelli, F.
Barni, S.
ANNALS OF ONCOLOGY, 2013, 24 (01) : 186 - 192
[5] A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)
Monk, Bradley J.
Parkinson, Christine
Lim, Myong Cheol
O'Malley, David M.
Oaknin, Ana
Wilson, Michelle K.
Coleman, Robert L.
Lorusso, Domenica
Bessette, Paul
Ghamande, Sharad
Christopoulou, Athina
Provencher, Diane
Prendergast, Emily
Demirkiran, Fuat
Mikheeva, Olga
Yeku, Oladapo
Chudecka-Glaz, Anita
Schenker, Michael
Littell, Ramey D.
Safra, Tamar
Chou, Hung-Hsueh
Morgan, Mark A.
Drochytek, Vit
Barlin, Joyce N.
Van Gorp, Toon
Ueland, Fred
Lindahl, Gabriel
Anderson, Charles
Collins, Dearbhaile C.
Moore, Kathleen
Marme, Frederik
Westin, Shannon N.
McNeish, Iain A.
Shih, Danny
Lin, Kevin K.
Goble, Sandra
Hume, Stephanie
Fujiwara, Keiichi
Kristeleit, Rebecca S.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (34) : 3952 - 3964
[6] Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib
Ogasawara, Sadahisa
Chiba, Tetsuhiro
Ooka, Yoshihiko
Suzuki, Eiichiro
Kanogawa, Naoya
Saito, Tomoko
Motoyama, Tenyu
Tawada, Akinobu
Kanai, Fumihiko
Yokosuka, Osamu
INVESTIGATIONAL NEW DRUGS, 2016, 34 (02) : 255 - 260
[7] POST-PROGRESSION SURVIVAL AFTER ERLOTINIB TREATMENT IN PATIENTS WITH ADVANCED NSCLC
Trojniak, M. P.
Palozzo, A. C.
Imbevaro, S.
Rescigno, P.
Pastorelli, D.
Jirillo, A.
ANNALS OF ONCOLOGY, 2012, 23 : 439 - 439
[8] Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib
Sadahisa Ogasawara
Tetsuhiro Chiba
Yoshihiko Ooka
Eiichiro Suzuki
Naoya Kanogawa
Tomoko Saito
Tenyu Motoyama
Akinobu Tawada
Fumihiko Kanai
Osamu Yokosuka
Investigational New Drugs, 2016, 34 : 255 - 260
[9] Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer
Van Le, Linda
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2020, 75 (01) : 29 - 31
[10] Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Gonzalez-Martin, A.
Pothuri, B.
Vergote, I.
DePont Christensen, R.
Graybill, W.
Mirza, M. R.
McCormick, C.
Lorusso, D.
Hoskins, P.
Freyer, G.
Baumann, K.
Jardon, K.
Redondo, A.
Moore, R. G.
Vulsteke, C.
O'Cearbhaill, R. E.
Lund, B.
Backes, F.
Barretina-Ginesta, P.
Haggerty, A. F.
Rubio-Perez, M. J.
Shahin, M. S.
Mangili, G.
Bradley, W. H.
Bruchim, I.
Sun, K.
Malinowska, I. A.
Li, Y.
Gupta, D.
Monk, B. J.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25): : 2391 - 2402

← 1 2 3 4 5 →